Related Experiment Video

Updated: Jul 18, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

Extended oligoarthritis and other risk factors for developing JIA-associated uveitis under ILAR classification and

Kuan T Sim1, Helen E Venning, Steve Barrett

  • 1Queens Medical Centre, Department of Ophthalmology and Visual Science, Nottingham, UK. kuantzen@doctors.org.uk

Ocular Immunology and Inflammation
|December 13, 2006
PubMed

Insights

Patients with extended oligoarthritis, a subtype of juvenile idiopathic arthritis (JIA), face a higher risk of developing uveitis. Early monitoring is crucial for these individuals to ensure favorable visual outcomes.

Area of Science:

  • Ophthalmology
  • Rheumatology
  • Pediatrics

Background:

  • Juvenile idiopathic arthritis (JIA) is a chronic autoimmune condition affecting children.
  • Uveitis is a serious ocular complication associated with JIA, potentially leading to vision loss.
  • Understanding risk factors for JIA-associated uveitis is crucial for timely intervention.

Purpose of the Study:

  • To identify risk factors for developing uveitis in a cohort of patients with JIA.
  • To analyze the visual outcomes in JIA patients with and without uveitis.
  • To evaluate the association between ILAR classification subtypes and uveitis development.

Main Methods:

  • Retrospective study of children diagnosed with JIA at Nottingham University Hospital (1974-2001).
  • Analysis of clinical factors associated with uveitis development and visual prognosis.
  • Kaplan-Meier analysis to assess risk across different ILAR subtypes.

Main Results:

  • 11.4% of 202 JIA patients developed uveitis.
  • Extended oligoarthritis and persistent oligoarthritis subtypes showed a significant risk for uveitis (p=0.001 and p=0.013).
  • Extended oligoarthritis had the highest uveitis prevalence (25%) and earlier onset compared to the persistent group.

Conclusions:

  • Patients with extended oligoarthritis are at increased risk of developing JIA-associated uveitis.
  • Close monitoring and tailored screening guidelines based on ILAR classification are recommended for high-risk JIA patients.
  • Favorable visual outcomes (90% achieving 6/12 acuity) were observed, emphasizing the importance of early detection and management.
Abstract

More Related Videos

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis10:33

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...